Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
The British Journal of Psychiatry. Supplement
|
November 26, 1998
Abecarnil, a new beta-carboline, in the treatment of anxiety disorders
B Aufdembrinke
Arzneimittel-Forschung
|
January 1, 1976
[Comparison of experimental-psychological and clinical findings on the effect of a test substance (author's transl)]
G Debus, B Aufdembrinke
Journal of Clinical Psychopharmacology
|
February 1, 2000
A double-blind, placebo-controlled trial of abecarnil and diazepam in the treatment of patients with generalized anxiety disorder
K Rickels, N DeMartinis, B Aufdembrinke
Psychopharmacology Series
|
January 1, 1988
Measures of memory and information processing in elderly volunteers
B Aufdembrinke, H Ott, A Rohloff
Psychopharmacology Series
|
January 1, 1988
Anterograde and retrograde amnesia after lormetazepam and flunitrazepam
H Ott, A Rohloff, B Aufdembrinke, et al.
EEG-EMG Zeitschrift Fur Elektroenzephalographie, Elektromyographie Und Verwandte Gebiete
|
September 1, 1981
[Electroencephalographically determined sedative effects (vigilosomnography) of the new Thienodiazepin-derivate clotiazepam (author's transl)]
B Aufdembrinke, J Kugler, M Laub, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
November 26, 1999
Pharmacodynamic comparison of single doses of IFN-beta1a and IFN-beta1b in healthy volunteers
S Stürzebecher, R Maibauer, A Heuner, et al.
Functional Neurology
|
May 1, 1995
Terguride in stable Parkinson's disease
E Martignoni, C Pacchetti, B Aufdembrinke, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 1, 1993
Terguride in fluctuating parkinsonian patients: a double-blind study versus placebo
C Pacchetti, E Martignoni, P Bruggi, et al.
Psychopharmacology
|
June 1, 1994
Negative symptoms in schizophrenia: considerations for clinical trials. Working group on negative symptoms in schizophrenia
H J Möller, H M van Praag, B Aufdembrinke, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
The British Journal of Psychiatry. Supplement
|
November 26, 1998
Abecarnil, a new beta-carboline, in the treatment of anxiety disorders
B Aufdembrinke
Arzneimittel-Forschung
|
January 1, 1976
[Comparison of experimental-psychological and clinical findings on the effect of a test substance (author's transl)]
G Debus, B Aufdembrinke
Journal of Clinical Psychopharmacology
|
February 1, 2000
A double-blind, placebo-controlled trial of abecarnil and diazepam in the treatment of patients with generalized anxiety disorder
K Rickels, N DeMartinis, B Aufdembrinke
Psychopharmacology Series
|
January 1, 1988
Measures of memory and information processing in elderly volunteers
B Aufdembrinke, H Ott, A Rohloff
Psychopharmacology Series
|
January 1, 1988
Anterograde and retrograde amnesia after lormetazepam and flunitrazepam
H Ott, A Rohloff, B Aufdembrinke, et al.
EEG-EMG Zeitschrift Fur Elektroenzephalographie, Elektromyographie Und Verwandte Gebiete
|
September 1, 1981
[Electroencephalographically determined sedative effects (vigilosomnography) of the new Thienodiazepin-derivate clotiazepam (author's transl)]
B Aufdembrinke, J Kugler, M Laub, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
November 26, 1999
Pharmacodynamic comparison of single doses of IFN-beta1a and IFN-beta1b in healthy volunteers
S Stürzebecher, R Maibauer, A Heuner, et al.
Functional Neurology
|
May 1, 1995
Terguride in stable Parkinson's disease
E Martignoni, C Pacchetti, B Aufdembrinke, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 1, 1993
Terguride in fluctuating parkinsonian patients: a double-blind study versus placebo
C Pacchetti, E Martignoni, P Bruggi, et al.
Psychopharmacology
|
June 1, 1994
Negative symptoms in schizophrenia: considerations for clinical trials. Working group on negative symptoms in schizophrenia
H J Möller, H M van Praag, B Aufdembrinke, et al.
Page
of 1